Cargando…
Combination Analgesic Development for Enhanced Clinical Efficacy (CADENCE Trial): Study Protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of an Alpha-Lipoic Acid – Pregabalin Combination for the Treatment of Fibromyalgia Pain
BACKGROUND: Fibromyalgia is a clinical disorder commonly presenting with chronic widespread pain as well as sleep disturbance, fatigue, depression, and cognitive dysfunction. There is an urgent need for treatment strategies that provide better pain relief and fewer adverse effects (AEs). Efforts to...
Autores principales: | Gilron, Ian, Tu, Dongsheng, Holden, Ronald, Towheed, Tanveer, Vandenkerkhof, Elizabeth, Milev, Roumen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705061/ https://www.ncbi.nlm.nih.gov/pubmed/28778847 http://dx.doi.org/10.2196/resprot.8001 |
Ejemplares similares
-
Innovations in the Management of Musculoskeletal Pain With Alpha-Lipoic Acid (IMPALA Trial): Study protocol for a Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Alpha-Lipoic Acid for the Treatment of Fibromyalgia Pain
por: Gilron, Ian, et al.
Publicado: (2017) -
Pain Improvement With Novel Combination Analgesic Regimens (PAIN-CARE): Randomized Controlled Trial Protocol
por: Gilron, Ian, et al.
Publicado: (2017) -
Melatonin for Neuropathic Pain: Protocol for a Double-blind, Randomized Controlled Trial
por: Gilron, Ian, et al.
Publicado: (2022) -
Pregabalin in Treatment-Refractory Fibromyalgia
por: Stacey, Brett R, et al.
Publicado: (2010) -
Pregabalin for the management of fibromyalgia syndrome
por: Boomershine, Chad S
Publicado: (2010)